These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2469946)

  • 1. Focal encephalopathy after cisplatin therapy.
    Gorman DJ; Kefford R; Stuart-Harris R
    Med J Aust; 1989 Apr; 150(7):399-401. PubMed ID: 2469946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathological report of cisplatin encephalopathy].
    Nomura K; Ohno R; Hamaguchi K; Hata T; Hatanaka H; Matsuyama H
    Rinsho Shinkeigaku; 1995 Jan; 35(1):64-9. PubMed ID: 7781218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-induced non-convulsive encephalopathy.
    Lyass O; Lossos A; Hubert A; Gips M; Peretz T
    Anticancer Drugs; 1998 Jan; 9(1):100-4. PubMed ID: 9491799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encephalopathy following cisplatin, bleomycin and vinblastine therapy for non-seminomatous germ cell tumour of testis.
    Hitchins RN; Thomson DB
    Aust N Z J Med; 1988 Feb; 18(1):67-8. PubMed ID: 2456056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
    Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ;
    J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-induced encephalopathy and seizures.
    Steeghs N; de Jongh FE; Sillevis Smitt PA; van den Bent MJ
    Anticancer Drugs; 2003 Jul; 14(6):443-6. PubMed ID: 12853886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cis-dichlorodiammine platinum (II) in advanced ovarian carcinoma.
    Stewart JF; Tattersall MH; Woods RL; Fox RM
    Med J Aust; 1979 Jun; 1(12):548-50. PubMed ID: 470725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin: an anti-tumour agent.
    Drug Ther Bull; 1979 Dec; 17(25):99-100. PubMed ID: 575631
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient cortical blindness during chemotherapy (PVB) for ovarian germ cell tumor.
    Manchana T; Sirisabya N; Lertkhachonsuk R; Tresukosol D
    J Med Assoc Thai; 2006 Aug; 89(8):1265-8. PubMed ID: 17048439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin.
    Cohen RJ; Cuneo RA; Cruciger MP; Jackman AE
    J Clin Oncol; 1983 Jun; 1(6):392-3. PubMed ID: 6199475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute encephalopathic toxicity of cisplatin.
    Verschraegen C; Conrad CA; Hong WK
    Lung Cancer; 1995 Dec; 13(3):305-9. PubMed ID: 8719070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin (Platinol).
    Med Lett Drugs Ther; 1979 Apr; 21(8):33-4. PubMed ID: 431486
    [No Abstract]   [Full Text] [Related]  

  • 13. Cortical blindness and seizures following cisplatin treatment: both of epileptic origin?
    van Gelder T; Geurs P; Kho GS; Dippel DW; Vecht CJ; Splinter TA
    Eur J Cancer; 1993; 29A(10):1497-8. PubMed ID: 8398283
    [No Abstract]   [Full Text] [Related]  

  • 14. Seizures in a patient with disseminated testicular cancer due to cisplatin-induced hypomagnesaemia.
    van de Loosdrecht AA; Gietema JA; van der Graaf WT
    Acta Oncol; 2000; 39(2):239-40. PubMed ID: 10859019
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose cisplatin-related peripheral neuropathy.
    Ostchega Y; Donohue M; Fox N
    Cancer Nurs; 1988 Feb; 11(1):23-32. PubMed ID: 2834044
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin-induced gastric paresis.
    Cohen SC; Mollman JE
    J Neurooncol; 1987; 5(3):237-40. PubMed ID: 2445937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for malignant glioma: an analysis of risk factors.
    Kapp JP; Sanford RA
    Neurosurgery; 1986 Nov; 19(5):779-83. PubMed ID: 3785625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis.
    von Schlippe M; Fowler CJ; Harland SJ
    Br J Cancer; 2001 Sep; 85(6):823-6. PubMed ID: 11556831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cerebral Venous Sinus Thrombosis Following Cisplatin-Based Chemotherapy for Testicular Tumor].
    Ishihara M; Satoh K; Hanaoka M; Matsuzaki K; Matsuda T; Miyake H; Niki H
    No Shinkei Geka; 2017 May; 45(5):417-422. PubMed ID: 28490684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas.
    Bonomi PD; Slayton RE; Wolter J
    Cancer Treat Rep; 1978 Aug; 62(8):1211-3. PubMed ID: 356979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.